Mature compounders rated Buy
Archetype-classified mature compounders currently rated Buy or Strong Buy by the analysis pipeline. Stable, capital-efficient businesses where the model agrees the price is supportive.
| # | Symbol | Company | Sector | Market cap | P/E | ROIC | Div. yield |
|---|---|---|---|---|---|---|---|
| 1 | GOOGL | Alphabet Inc. | Communication Services | $4.86T | 30.58 | +28.3% | +0.2% |
| 2 | V | Visa Inc. | Financials | $600.64B | 27.79 | +54.3% | +0.8% |
| 3 | ORCL | Oracle Corporation | Technology | $563.56B | 35.16 | +12.0% | +1.0% |
| 4 | JNJ | Johnson & Johnson | Healthcare | $532.77B | 25.63 | +13.3% | +2.4% |
| 5 | MA | Mastercard Incorporated | Financials | $437.80B | 28.66 | +95.2% | +0.7% |
| 6 | NFLX | Netflix, Inc. | Communication Services | $368.40B | 28.26 | +33.1% | 0.0% |
| 7 | KO | The Coca-Cola Company | Consumer Staples | $337.40B | 24.66 | +19.6% | +2.7% |
| 8 | PM | Philip Morris International Inc. | Consumer Staples | $266.50B | 24.08 | +35.3% | +3.4% |
| 9 | MCD | McDonald's Corporation | Consumer Discretionary | $195.92B | 22.73 | +18.8% | +2.7% |
| 10 | NEE | NextEra Energy, Inc. | Utilities | $194.15B | 23.64 | +3.1% | +2.7% |
| 11 | AMGN | Amgen Inc. | Healthcare | $179.02B | 23.09 | +19.1% | +3.0% |
| 12 | UBER | Uber Technologies, Inc. | Technology | $153.59B | 18.65 | +19.3% | 0.0% |
| 13 | CRM | Salesforce, Inc. | Technology | $148.74B | 23.31 | +10.9% | +1.0% |
| 14 | BKNG | Booking Holdings Inc. | Consumer Discretionary | $128.58B | 21.78 | +57.9% | +1.0% |
| 15 | SPGI | S&P Global Inc. | Financials | $124.35B | 26.60 | +10.8% | +0.9% |
| 16 | INTU | Intuit Inc. | Technology | $109.60B | 25.74 | +19.0% | +1.2% |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | $109.09B | 25.49 | +28.6% | 0.0% |
| 18 | ADBE | Adobe Inc. | Technology | $102.28B | 14.75 | +63.3% | 0.0% |
| 19 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | $72.73B | 17.41 | +12.9% | +0.5% |
| 20 | PYPL | PayPal Holdings, Inc. | Financials | $40.02B | 8.50 | +22.9% | +1.2% |
Frequently asked
About this screen
- What is the mature-compounder archetype?
- An archetype reserved for businesses with a multi-year track record of single-to-low-double-digit revenue growth, stable or expanding margins, high return on invested capital, and conservative balance sheets. The classification calibrates downstream parameters (terminal growth, margin of safety, deceleration curve) and is set in Phase 0 of every analysis run.
- Why pair it with a Buy or Strong Buy rating?
- The archetype is a quality screen; the rating is a price screen. The combination filters to compounders where the platform's valuation models also agree the current price is supportive — a higher bar than 'good business at any price'.
- Do mature compounders get a higher margin of safety?
- No — typically lower. The platform applies a 15% margin of safety for businesses scoring 8-10 on quality, scaled up to 30% for weaker businesses. Mature compounders with high quality scores generally cluster at the lower end.
Other screens